CRISTINA PEREZ: Open Payments
NPI 1861859084 · SAN BERNARDINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,136 in 29 payments from 8 companies in 2025. Trend: 2023 $2,176 · 2024 $1,617 · 2025 $1,136
Food & beverage: $1,136
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 7 | $319 |
| Novo Nordisk Inc | 4 | $267 |
| Amgen Inc. | 9 | $249 |
| Ardelyx, Inc. | 5 | $199 |
| Dexcom, Inc. | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Fresenius USA Marketing, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: Vafseo, KRYSTEXXA, Wegovy, XPHOZAH 30 MG, IBSRELA, Ozempic, Dexcom G6 Transmitter, OFEV.
Industry payments across CA — which companies pay providers there.
